Recombinant Human Papillomavirus Nonavalent Vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Gardasil 9, Nonavalent HPV VLP Vaccine, Recombinant HPV Nonavalent Vaccine, Recombinant Human Papillomavirus 9-valent Vaccine

Filter by location:

Birmingham, Alabama1 trial

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

University of Alabama at Birmingham Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.